Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 42
Filter
1.
Hum Fertil (Camb) ; 15(3): 134-9, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22812907

ABSTRACT

This randomized controlled trial investigated whether delaying human chorionic gonadotrophin hormone (hCG) administration within an IVF cycle impacts upon clinical outcomes. Participants included 125 women undergoing IVF/ICSI cycles at Leeds Centre for Reproductive Medicine. Subjects were aged 20-36 years, body mass index (BMI) 20-30 kg/m(2) with a normal FSH level (<8 IU/l). Administration of hCG took place 35-36 h prior to oocyte retrieval when there were ≥3 follicles ≥17 mm in diameter (Group A), delayed by 1 day (Group B) or 2 days (Group C). Outcomes included the number of oocytes retrieved per cycle, fertilization rate and live birth rate. On the day of oocyte retrieval, women in Groups B and C had significantly more mature follicles than Group A, although the number of oocytes retrieved did not differ (median = 12 in each group). Fertilization rates and embryo quality were comparable between groups. Pregnancies and live births per cycle were higher in Groups B and C (A = 30.8%, B = 54.1%, C = 38.7%; A = 17.9%, B = 27.0%, C = 25.8%), but did not reach statistical significance. Delaying hCG administration had no significant negative impact upon morphological quality of embryos, availability of surplus embryos for freezing or pregnancy outcomes. Postponing hCG may enable increased flexibility of cycle scheduling to avoid weekend procedures.


Subject(s)
Chorionic Gonadotropin/administration & dosage , Fertilization in Vitro/methods , Gonadotropin-Releasing Hormone/antagonists & inhibitors , Adult , Female , Humans , Live Birth , Oocyte Retrieval , Oocytes , Pregnancy , Sperm Injections, Intracytoplasmic/methods , Time Factors , Treatment Outcome
2.
Int J STD AIDS ; 18(5): 308-11, 2007 May.
Article in English | MEDLINE | ID: mdl-17524189

ABSTRACT

Hormonal changes may be important in the onset and clearance of bacterial vaginosis. We studied vaginal flora and serum oestradiol levels of 55 women at baseline and during hormonal treatment. None developed bacterial vaginosis (BV) from normal vaginal flora, 69% of women had normal flora at baseline increasing to 91% following hormonal treatment. The mean oestradiol level with BV was 39.07 ng/L compared with 176.41 ng/L with normal flora. Non-smokers had a mean oestradiol level of 173.95 ng/L compared with 118.67 ng/L in smokers. Recombinant follicle-stimulating hormone resulted in a mean oestradiol rise of 113.9 ng/L. The mean rise was 330.4 ng/L with improved vaginal flora but only 15.1 ng/L in persistently abnormal or worsening flora. A rise in oestradiol in this group of women was associated with a significant reduction of abnormal flora. Reversion from BV to normal flora was associated with a greater rise in oestradiol than where abnormal flora persisted or worsened. This study supports a possible hormonal influence in the natural history of BV. The lower oestradiol levels in smokers may help explain their increased risk of BV.


Subject(s)
Estradiol/blood , Vagina/microbiology , Vaginosis, Bacterial , Adult , Bacteria/growth & development , Estradiol/metabolism , Estrogens/metabolism , Estrogens/therapeutic use , Female , Follicle Stimulating Hormone/therapeutic use , Humans , Pilot Projects , Recombinant Proteins/therapeutic use , Smoking/adverse effects , Vagina/drug effects , Vagina/physiology
3.
Zygote ; 15(1): 81-90, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17391548

ABSTRACT

Oligoasthenoteratozoospermia (OAT) is defined by a combined low count < 20 x 10(6) sperm/ml, poor motility < 50 % forward progression or < 25 % rapid linear progression and abnormal morphology (5-8 % normal using Kruger strict criteria) and has been associated with increased levels of sperm aneuploidy. Here we report on the cytogenetic findings from three 'spare' embryos from a couple that were referred for ICSI because of OAT. The embryos were processed for sequential FISH in three hybridization rounds using probes for chromosomes 3, 7, 9, 13, 17, 18, 21, X and Y. Molecular cytogenetic analysis of nine chromosomes revealed that all three embryos were female polyploid. One of them was uniformly tetraploid for all chromosomes tested, while the remaining two embryos showed evidence of abnormal postzygotic segregation of chromosomes, causing the derivative blastomeres to have uneven chromosomal constitution. In one of them in particular, the non-disjoining chromosomes showed preferential segregation to the same pole, rather than randomly moving towards either pole, suggesting an abnormal spindle and causing the derivative blastomeres to have significantly uneven chromosomal constitutions. The possible scenarios leading to polyploidy and chromosomal imbalance through cytokinetic failure and subsequent abnormal centrosomal distribution are outlined.


Subject(s)
Asthenozoospermia/genetics , Centrosome/ultrastructure , Cleavage Stage, Ovum/ultrastructure , Oligospermia/genetics , Polyploidy , Spermatozoa/ultrastructure , Adult , Embryonic Development/genetics , Female , Humans , In Situ Hybridization, Fluorescence , In Vitro Techniques , Male , Models, Genetic , Sperm Injections, Intracytoplasmic
4.
Mol Reprod Dev ; 67(3): 323-36, 2004 Mar.
Article in English | MEDLINE | ID: mdl-14735494

ABSTRACT

Recent evidence indicates that mammalian gametogenesis and preimplantation development may be adversely affected by both assisted reproductive and stem cell technologies. Thus, a better understanding of the developmental regulation of the underlying epigenetic processes that include DNA methylation is required. We have, therefore, monitored the expression, by PCR, of the mRNAs of DNA methyltransferases (DNMTs), methyl-CpG-binding domain proteins (MBDs), and CpG binding protein (CGBP) in a developmental series of amplified cDNA samples derived from staged human ovarian follicles, oocytes, preimplantation embryos, human embryonic stem (hES) cells and in similar murine cDNA samples. Transcripts of these genes were detected in human ovarian follicles (DNMT3A, DNMT3b1, DNMT3b4, DNMT1, MDBs1-4, MeCP2, CGBP), germinal vesicle (GV) oocytes (DNMT3A, DNMT3b1, DNMT1, MDBs1-4, MeCP2, CGBP), mature oocytes (DNMT3A, DNMT3b1, DNMT1, CGBP), and preimplantation embryos (DNMT3A, DNMT3b1, DNMT1, DNMT3L, MBD2, MDB4, CGBP). Differential expression of DNMT3B gene transcripts in undifferentiated (DNMT3b1) and in vitro differentiated human ES cells (DNMT3b3) further demonstrated an association of the DNMT3b1 transcript variant with totipotent and pluripotent human cells. Significantly, whilst the murine Dnmt3L gene is both expressed and essential for imprint establishment during murine oogenesis, transcripts of the human DNMT3L gene were only detected after fertilisation. Therefore, the mechanisms and/or the timing of imprint establishment may differ in humans.


Subject(s)
Blastocyst/metabolism , DNA Modification Methylases/genetics , DNA-Binding Proteins/genetics , Ovum/metabolism , Stem Cells/metabolism , DNA Modification Methylases/biosynthesis , DNA-Binding Proteins/biosynthesis , Female , Humans , Pregnancy , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction
5.
Mol Hum Reprod ; 8(12): 1087-95, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12468641

ABSTRACT

The Factor In the Germline alpha (FIGalpha) transcription factor regulates expression of the zona pellucida proteins ZP1, ZP2 and ZP3 and is essential for folliculogenesis in the mouse. Using the published mouse Figla sequence, BLAST searches identified a human chromosome 2 BAC clone with high sequence identity. Using PCR primers derived from this clone, amplicons derived from ovarian follicles and mature oocytes revealed 100% identity with the appropriate human BAC clone, the expected homology with the mouse Figla gene sequence, and homology on translation with the FIGalpha protein identified in the Japanese rice fish, medaka (Oryzias latipes). PCR expression profiling of this transcript revealed FIGLA mRNA expression in cDNA derived from ovarian follicles (5/5 samples from the primordial through to the secondary stage) mature oocytes (6/9 samples), and less frequently in preimplantation embryos (2/7 samples). Subsequent BLAST searches revealed the predicted full length coding sequence of the human FIGalpha protein which demonstrates 68 and 25% similarity overall to mouse and medaka proteins respectively, with 96 and 57% identity respectively within the basic helix-loop-helix region. This confirms our identification of the human homologue for this gene which maps to chromosome 2p12. Further work is required to understand its role in normal human oocyte development and the potential involvement in human infertility.


Subject(s)
DNA-Binding Proteins/genetics , Oocytes/metabolism , Ovarian Follicle/metabolism , Receptors, Cell Surface , Transcription Factors/genetics , Alternative Splicing , Amino Acid Sequence , Animals , Base Sequence , Basic Helix-Loop-Helix Transcription Factors , Blastocyst/metabolism , DNA-Binding Proteins/metabolism , Egg Proteins/genetics , Female , Humans , Membrane Glycoproteins/genetics , Mice , Molecular Sequence Data , Octamer Transcription Factor-3 , Transcription Factors/metabolism , Zona Pellucida Glycoproteins
6.
Fertil Steril ; 76(4): 837-40, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11591425

ABSTRACT

OBJECTIVE: To evaluate the potential of Multifluor fluorescence in situ hybridization (M-FISH) for karyotyping the human oocyte and first polar body. DESIGN: Prospective case study. SETTING: Research laboratories, university hospital. PATIENT(S): A 33-year-old woman with polycystic ovary syndrome who was undergoing ovarian stimulation and ICSI. MAIN OUTCOME MEASURE(S): Karyotyping of all chromosomes within an oocyte and first polar body, using GV stage oocytes matured to metaphase II in vitro. RESULT(S): Oocyte hyperploidy was diagnosed by M-FISH to be 23, X +15 cht +19 cht +22 cht. The correspond- ing polar body was hypoploid, with a karyotype of 23, X -15 cht -19 cht -22 cht. This was due to unbalanced predivision at meiosis I. Reprobing confirmed karyotype assignments for chromosomes X, 13, 18, and 21. CONCLUSION(S): The mechanism involved in maternally derived aneuploidy can be defined by using M-FISH to simultaneously karyotype both oocyte and first polar body chromosomes at metaphase II. Multifluor FISH may be useful for investigative studies of maternally derived aneuploidy, which is a major cause of preimplantation waste in natural and assisted reproduction.


Subject(s)
Aneuploidy , In Situ Hybridization, Fluorescence , Oocytes/physiology , Adult , Female , Humans , Karyotyping , Prospective Studies
7.
Hum Reprod ; 16(10): 2056-60, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11574491

ABSTRACT

BACKGROUND: Ovarian failure is a common sequel to chemo/radiotherapy in patients successfully treated for cancer. Harvesting, cryopreserving and subsequently re-implanting ovarian cortical grafts can be used to re-establish reproductive potential in women with cancer. The safety issue, however, is of great concern because residual disease in autografted ovarian tissues might cause recrudescence of disease. METHODS: A total of 30 non-obese diabetic severe combined immunodeficient (NOD/LtSz-SCID) mice were individually xenografted s.c. with frozen-thawed ovarian tissue from 18 patients with lymphoma [13 Hodgkin's lymphoma (HL) and 5 non-Hodgkin's lymphoma (NHL)]. The animals were autopsied at 16 weeks, or earlier if cachectic. The xenograft, liver, spleen, sternum, para-aortic lymph nodes and thymus were prepared for histology, immunohistochemistry and human DNA microsatellite analysis. RESULTS: None of the animals grafted with ovarian tissue from lymphoma patients developed disease. However, all 3 animals grafted with lymph node tissue from an NHL patient developed B-cell lymphomas that were confirmed as human in origin by DNA microsatellite analysis. CONCLUSION: Ovarian tissue harvested before high-dose chemotherapy for HL or NHL may not carry a risk of disease transmission by autotransplantation, although the possibility is difficult to exclude completely.


Subject(s)
Fertility , Infertility, Female/prevention & control , Lymphoma/physiopathology , Lymphoma/surgery , Ovary/transplantation , Tissue and Organ Harvesting , Adult , Animals , Female , Hodgkin Disease/physiopathology , Hodgkin Disease/surgery , Humans , Lymphoma, B-Cell/genetics , Lymphoma, B-Cell/pathology , Lymphoma, Non-Hodgkin/genetics , Lymphoma, Non-Hodgkin/physiopathology , Lymphoma, Non-Hodgkin/surgery , Mice , Mice, SCID , Microsatellite Repeats , Neoplasm Invasiveness , Ovary/pathology , Thymus Gland/pathology , Transplantation, Autologous , Transplantation, Heterologous
9.
Lancet ; 355(9214): 1520-1, 2000 Apr 29.
Article in English | MEDLINE | ID: mdl-10801178

ABSTRACT

When a preovulatory oocyte reinitiates meiosis, it sheds a cytoplasmic fragment containing mitochondria and a redundant set of chromosomes. We have detected DNA sequences from both the mitochondrial and nuclear genomes in polar bodies from unfertilised human oocytes, demonstrating the feasibility of diagnosing mitochondrial diseases before conception.


Subject(s)
Glyceraldehyde-3-Phosphate Dehydrogenases/genetics , Mitochondrial Myopathies/diagnosis , Oocytes , Base Sequence , DNA, Mitochondrial/genetics , Electrophoresis, Agar Gel , Female , Humans , Polymerase Chain Reaction
10.
BJOG ; 107(3): 369-74, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10740334

ABSTRACT

OBJECTIVE: To examine the incidence of ectopic pregnancy over the period 1966 to 1996. SETTING: England and Wales. DESIGN: Use of official statistics on hospital discharges, maternities, legal abortions and estimated populations of women aged 15-44 years. MAIN OUTCOME MEASURES: Incidence rates of ectopic pregnancies. RESULTS: Between 1966 to 1970 and 1994 to 1996 the recorded incidence increased 4.5-fold from 3.45 to 15.5 per 1000 maternities, 3.8-fold from 3.25 to 12.4 per 1000 pregnancies and 3.1-fold from 30.2 to 94.8 per 100,000 women aged 15-44. The rate of increase was not uniform. Incidence approximately doubled between 1966 and 1985, when the official data collection system changed. By 1989, when data from the new system became available, there had been a further almost doubling of recorded incidence. Subsequently, the upward trend appears to have continued until 1991 to 1992 and has remained stable in the last four years of the study. The trends were similar in each of three 10-year age groups. CONCLUSIONS: The recorded incidence of ectopic pregnancy has increased markedly over the last three decades. This may be partly due to artefacts of data recording and more sensitive diagnostic tests, but it is likely that the actual incidence has increased, probably due to a sexually transmitted agent.


Subject(s)
Pregnancy, Ectopic/epidemiology , Adolescent , Adult , England/epidemiology , Female , Humans , Incidence , Pregnancy , Wales/epidemiology
12.
Hum Reprod ; 14(9): 2268-73, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10469693

ABSTRACT

Pregnancies achieved from oocyte, sperm or embryo donation are unique, since they have resulted from donor gametes that are immunologically foreign to the mother. Thus, studying the obstetric outcome of such pregnancies may shed some light on the pathophysiology of preeclampsia, particularly in women conceiving with donated embryos, since the entire fetal genome is allogenic in these pregnancies. In this retrospective cohort study, a total of 144 women were studied. Of these, 72 were infertility patients who had conceived as a result of sperm, ovum or embryo donation and the other 72 women were age- and parity-matched control patients who became pregnant with their own gametes, either spontaneously, or following intrauterine insemination with their partner's spermatozoa. Study patients were divided into three groups depending on the origin of the donated gametes. Group 1 consisted of pregnancies achieved by intrauterine insemination with washed donor spermatozoa (n = 33). Group 2 included women who conceived using donated oocytes (n = 27) and group 3 consisted of women who conceived as a result of embryo donation (n = 12). The incidence of pregnancy-induced hypertension in the donated gametes study group was 12.5% (9/72) compared with 2.8% (2/72) in the control group. In addition, pre-eclampsia was diagnosed in 18.1% (13/72) of the donated gametes study group compared to 1.4% (1/72) in the age- and parity-matched controls. The increased incidence of gestational hypertension in pregnancies resulting from donated gametes gives evidence for a maternal genetic component, with an equally strong fetal influence, in the complicated aetiology of gestational hypertension, and pre-eclampsia in particular.


Subject(s)
Embryo, Mammalian , Hypertension/epidemiology , Oocyte Donation , Pregnancy Complications, Cardiovascular/epidemiology , Tissue Donors , Cohort Studies , Female , Humans , Insemination, Artificial, Heterologous , Pre-Eclampsia/epidemiology , Pregnancy , Retrospective Studies
14.
Fertil Steril ; 72(2): 229-32, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10438985

ABSTRACT

OBJECTIVE: To determine whether excluding glucose from the culture medium used in a clinical IVF program improves human embryo quality and pregnancy rates. DESIGN: Randomized controlled trial. SETTING: Clinical assisted conception laboratory in a large teaching hospital. PATIENT(S): Seven hundred forty-one patients undergoing IVF-ET. INTERVENTION(S): Embryos were cultured from the pronucleate stage to ET in medium with glucose for patients in the control group and without glucose for patients in the trial group. MAIN OUTCOME MEASURE(S): Comparison of embryo quality and pregnancy rates between the two groups. RESULT(S): Embryo quality was enhanced with the use of glucose-free medium but pregnancy rates were similar. CONCLUSION(S): Although pregnancy rates remained similar in the two groups, a reduction in the glucose concentration of the medium used for embryo culture from the pronucleate stage to ET on day 2 or 3 is prudent.


Subject(s)
Culture Media , Embryo Transfer/methods , Fertilization in Vitro/methods , Glucose , Pregnancy/statistics & numerical data , Adult , Female , Humans , Pregnancy, Multiple/statistics & numerical data , Prospective Studies , Treatment Outcome
15.
BMJ ; 319(7204): 220-3, 1999 Jul 24.
Article in English | MEDLINE | ID: mdl-10417083

ABSTRACT

OBJECTIVES: To assess whether bacterial vaginosis affects the rates of conception and miscarriage in the first trimester. DESIGN: Cohort study. SETTING: Assisted conception unit of a teaching hospital in Leeds. PARTICIPANTS: 867 consecutive women undergoing in vitro fertilisation. INTERVENTIONS: Screening for bacterial vaginosis with a Gram stained vaginal smear before egg collection. MAIN OUTCOME MEASURES: The presence of bacterial vaginosis or normal vaginal flora, and the rate of conception and miscarriage in the first trimester. RESULTS: 190 of 771 (24.6%) women had bacterial vaginosis. No difference in conception rate was found between those women with bacterial vaginosis and those with normal vaginal flora: 61 women (32.1%) and 146 of 493 women (29.6%) respectively (relative risk 1. 08, 95% confidence interval 0.85 to 1.39; odds ratio 1.12, 0.77 to 1. 64). However, 22 women (31.6%) with bacterial vaginosis who conceived had a significantly increased risk of miscarriage in the first trimester compared with 27 women (18.5%) with normal vaginal flora (crude relative risk 1.95, 1.11 to 3.42; crude odds ratio 2.49, 1.21 to 5.12). This increased risk remained significant after adjustment for factors known to increase the rate of miscarriage: increasing maternal age, smoking, history of three or more miscarriages, no previous live birth, and polycystic ovaries (adjusted relative risk 2.03, 1.09 to 3.78; adjusted odds ratio 2.67, 1.26 to 5.63). CONCLUSIONS: Bacterial vaginosis does not affect conception but is associated with an increased risk of miscarriage in the first trimester in women undergoing in vitro fertilisation, independent of other risk factors.


Subject(s)
Abortion, Spontaneous/etiology , Infertility, Female/etiology , Vaginosis, Bacterial/complications , Cohort Studies , Female , Fertilization in Vitro , Humans , Pregnancy , Pregnancy Trimester, First , Risk Factors
18.
Fertil Steril ; 71(5): 948-51, 1999 May.
Article in English | MEDLINE | ID: mdl-10231063

ABSTRACT

OBJECTIVE: To evaluate the efficacy of a newly designed round biopter as a practical and safe method for collecting ovarian tissue for cryopreservation in young women with cancer before chemotherapy. DESIGN: Prospective study of young women volunteering for research (Leeds, United Kingdom) and patients with cancer (Jerusalem, Israel and Leeds, United Kingdom) undergoing laparoscopic ovarian cortical tissue biopsy and cryopreservation before administration of high-dose radiochemotherapy. SETTING: Two university-based tertiary referral centers of oncology and gynecology (Hadassah Medical Center, Israel; Leeds General Infirmary, United Kingdom). PATIENT(S): Twenty female volunteers undergoing routine laparoscopic gynecologic procedures (age, 25-34 years) and 20 young women (age, 11-30 years) with advanced cancer requiring potentially sterilizing radiochemotherapy. INTERVENTION(S): Cortical ovarian tissue biopsies performed under laparoscopy with use of the round biopter. RESULT(S): The laparoscopic sampling procedure was uncomplicated in all cases. In treated patients, five to six samples were obtained (5 mm in diameter; 2-3 mm in depth) using the round biopter, and radiochemotherapy was administered without delay. In volunteers, no adhesions were noted at repeat laparoscopy (9 patients). All biopsy specimens were cryopreserved, and histologic examination confirmed the presence of many primordial follicles. CONCLUSION(S): Laparoscopic ovarian biopsy performed with the round biopter is a safe and efficient method for collecting ovarian tissue for cryopreservation in patients with cancer.


Subject(s)
Antineoplastic Agents/adverse effects , Biopsy/instrumentation , Laparoscopes , Neoplasms/drug therapy , Neoplasms/radiotherapy , Ovary , Adolescent , Adult , Biopsy/methods , Child , Cryopreservation , Female , Humans , Ovary/drug effects , Ovary/radiation effects , Prospective Studies , Radiotherapy/adverse effects
19.
Fertil Steril ; 71(1): 106-8, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9935125

ABSTRACT

OBJECTIVE: To determine whether a starting dose of 50 units of recombinant FSH (follitropin beta, Puregon; Organon Laboratories Limited, Cambridge, United Kingdom) produces a follicular response in patients with clomiphene citrate-resistant polycystic ovary syndrome (PCOS). DESIGN: Prospective observational study. SETTING: Routine clinical practice in a teaching hospital fertility unit. PATIENT(S): Patients with clomiphene citrate-resistant PCOS who wanted to become pregnant. INTERVENTION(S): Low-dose step-up protocol of SC recombinant FSH administration, monitored prospectively by transvaginal ultrasonography and retrospectively by serum endocrine assays taken at each monitoring visit. MAIN OUTCOME MEASURE(S): Rate and size of follicular growth, recombinant FSH requirement, E2 response, ovulation, cycle cancellation, and pregnancy. RESULT(S): All patients exhibited a follicular response: Six patients ovulated, of whom two conceived and four had their cycles cancelled because of overstimulation. One patient did not ovulate despite the development of a follicle. CONCLUSION(S): Recombinant FSH can be used successfully to stimulate follicular growth at a starting dose of 50 IU.


Subject(s)
Follicle Stimulating Hormone/pharmacology , Ovulation Induction , Polycystic Ovary Syndrome/physiopathology , Adult , Clomiphene/pharmacology , Drug Resistance , Estradiol/pharmacology , Female , Fertility Agents, Female/pharmacology , Follicle Stimulating Hormone, Human , Humans , Ovarian Follicle/drug effects , Prospective Studies , Recombinant Proteins/pharmacology , Retrospective Studies , Stimulation, Chemical
20.
Acta Paediatr Suppl ; 88(433): 13-8, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10626539

ABSTRACT

Strategies to preserve fertility in young women undergoing potentially curative chemotherapy for malignant disease have been extremely limited. This limitation stems from the complex physiology of the human oocyte and the difficulties encountered in attempting to cryopreserve both developing and mature oocytes in sufficient quantities. Although in vitro fertilization and embryo cryopreservation can be used in those young women with a partner, this technique is unsuitable for the vast majority of patients and offers only a small chance of a pregnancy. Advances in cryobiology coupled with encouraging results in laboratory animals have prompted research into the storage of ovarian cortical tissue, which in young women is rich in primordial follicles. This tissue can be grafted back into the host, theoretically restoring the possibility of normal fertility. Primordial follicles contain oocytes at their least differentiated stage and appear to be relatively resistant to the combined insults of cryopreservation and the subsequent grafting procedure. Interest in this technique has been fuelled by its successful application in large domestic animals, such that ovarian tissue banking is being rapidly adopted into clinical practice before there is any hard evidence of its efficacy in humans.


Subject(s)
Cryopreservation , Ovary , Animals , Female , Fertilization in Vitro , Humans , Laparoscopy , Ovariectomy
SELECTION OF CITATIONS
SEARCH DETAIL
...